Navigation Links
Scientists develop an engineered cardiac tissue model to study the human heart
Date:1/30/2014

When it comes to finding cures for heart disease scientists are working to their own beat. That's because they may have finally developed a tissue model for the human heart that can bridge the gap between animal models and human patients. These models exist for other organs, but for the heart, this has been elusive. Specifically, the researchers generated the tissue from human embryonic stem cells with the resulting muscle having significant similarities to human heart muscle. This research was published in the February 2014 issue of The FASEB Journal.

"We hope that our human engineered cardiac tissues will serve as a platform for developing reliable models of the human heart for routine laboratory use," said Kevin D. Costa, Ph.D., a researcher involved in the work from the Cardiovascular Cell and Tissue Engineering Laboratory, Cardiovascular Research Center, Icahn School of Medicine at Mt. Sinai, in New York, NY. "This could help revolutionize cardiology research by improving the ability to efficiently discover, design, develop and deliver new therapies for the treatment of heart disease, and by providing more efficient screening tools to identify and prevent cardiac side effects, ultimately leading to safer and more effective treatments for patients suffering from heart disease."

To make this advance, Costa and colleagues cultured human engineered cardiac tissue, or hECTs, for 7-10 days and they self-assembled into a long thin heart muscle strip that pulled on the end-posts and caused them to bend with each heart beat, effectively exercising the tissue throughout the culture process. These hECTs displayed spontaneous contractile activity in a rhythmic pattern of 70 beats per minute on average, similar to the human heart. They also responded to electrical stimulation. During functional analysis, some of the responses known to occur in the natural adult human heart were also elicited in hECTs through electrical and pharmacological interventions, while some paradoxical responses of hECTs more closely mimicked the immature or newborn human heart. They also found that these human engineered heart tissues were able to incorporate new genetic information carried by adenovirus.

"We've come a long way in our understanding of the human heart," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal, "but we still lack an adequate tissue model which can be used to test promising therapies and model deadly diseases. This advance, if it proves successful over time, will beat anything that's currently available."


'/>"/>
Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
2. Queens scientists seek vaccine for Pseudomonas infection
3. Scientists produce eye structures from human blood-derived stem cells
4. American Society of Plant Biologists honors early career women scientists
5. Brandeis scientists win prestigious prize for circadian rhythms research
6. Scientists discover new method of proton transfer
7. Salk scientists open new window into how cancers override cellular growth controls
8. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
9. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
10. UGA scientists reveal genetic mutation depicted in van Goghs sunflower paintings
11. Genetic mutation depicted in van Goghs sunflower paintings revealed by scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2020)... ... 2020 , ... CrucialTrak, a global designer and manufacturer of biometric access control ... to market and sell its complete line of biometric readers and access gates ... optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for the ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will ... which will take place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... specializing in background and medical screening, announces the launch of a testing ... their workforce safe. The new service is provided by ClearStar’s Medical Information ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... ... April 06, 2020 , ... ... the life sciences industry, has announced the release of at-home virtual learning resources ... priority is the health and safety of our employees as we continue to ...
(Date:4/1/2020)... Texas (PRWEB) , ... March 30, 2020 , ... ... (APMD) and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to ... COVID-19 pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an ...
(Date:4/1/2020)... and LA JOLLA, Calif. (PRWEB) , ... March 31, 2020 , ... ... and La Jolla Institute for Immunology (LJI), announced today that they will use Carterra’s ... CoVIC to move therapeutic candidates to the clinic as early as this summer. , ...
(Date:3/27/2020)... ... March 25, 2020 , ... ... opening of its veterinary histopathology laboratory located centrally in the midwest for ... ability to work with a highly motivated, independent, professional team that is ...
Breaking Biology Technology: